For treating active autoantibody positive systemic lupus erythematosus
In line with NICE TA752.
Implementation date 15th March 2022
Date of classification
Medicines which should be prescribed only in a specialist setting usually within a secondary or tertiary care service. NB: Some highly specialised RED medicines e.g. injectable treatments for cancer are not included on the LLR APC website list.